Dr Catherine Pell

Dr Catherine Pell

Conjoint Senior Lecturer
Medicine & Health
The Kirby Institute

Cathy Pell is a Sexual Health Physician and a Vocationally Registered General Practitioner. She completed her training at Sydney, Pt Kembla and St George Sexual Health clinics, general practice in Wollongong and Family Planning clinics in Wollongong and Hurstville, before joining Taylor Square Private Clinic where she is a co-Director.  Cathy spent  2 years in Darwin as the Sexual Health Physician for the Northern Territory Department of Health and Families (DHF). In this role she saw patients in the public sexual health clinic in Darwin three days a week and spent the remainder of her time working in the Sexual Health and Blood Borne Virus Unit based at Royal Darwin Hospital. This unit provides oversight of programmes in the NT and Dr Pell worked on updating policies in sexual health, provided consultancy for health care workers in the NT and collaborated on a research project with DHF, AMSANT, Menzies School of Health Research and the National Centre in HIV Epidemiology and Clinical Research in improving delivering of sexual health services in primary care settings in remote areas of the NT.

Broad Research Areas

Sexual health, sexually transmissible infections, epidemiology, human immunodeficiency virus and human papilloma virus infection.

Qualifications

FAChSHM
MM

Society Memberships & Professional Activities

Senior Fellow of the Australasian College of Sexual Health Physicians
Fellow of the Australasian Chapter of Sexual Health Medicine within the Royal Australasian College of Physicians
Clinical Advisor to Australasian Society of HIV Medicine (ASHM)
Committee member involved in development of National HIV testing guidelines, National HIV Strategy
Member of Kirby Institute’s Primary Infection Working Group

  • Journal articles | 2021
    Dharan NJ; Yeh P; Bloch M; Yeung MM; Baker D; Guinto J; Roth N; Ftouni S; Ognenovska K; Smith D; Hoy JF; Woolley I; Pell C; Templeton DJ; Fraser N; Rose N; Hutchinson J; Petoumenos K; Dawson SJ; Polizzotto MN; Dawson MA; Vincent T; Rosario R; Lau H; Smith D; Price S; O’Brien J; Tan HTL; Sinclair B; Bascombe F, 2021, 'HIV is associated with an increased risk of age-related clonal hematopoiesis among older adults', Nature Medicine, 27, pp. 1006 - 1011, http://dx.doi.org/10.1038/s41591-021-01357-y
    Journal articles | 2021
    Gray J; Prestage G; Jin F; Phanuphak N; Friedman RK; Fairley CK; Kelleher A; Templeton D; Zablotska-Manos IB; Hoy J; McNulty A; Pell C; Grulich A; Bavinton B; Grinsztejn B; Cooper DA; Emery S; Wilson D; Koelsch KK; Triffitt K; Doong N; Baker D; Bloch M; Tee BK; Moore R; Roth N; Orth D; Pinto AN, 2021, 'Characteristics of Agreements to have Condomless Anal Intercourse in the Presence of an Undetectable Viral Load Among HIV Serodiscordant Male Couples in Australia, Brazil and Thailand', AIDS and Behavior, 25, pp. 3944 - 3954, http://dx.doi.org/10.1007/s10461-021-03324-7
    Journal articles | 2019
    Bavinton BR; Prestage GP; Jin F; Phanuphak N; Grinsztejn B; Fairley CK; Baker D; Hoy J; Templeton DJ; Tee BK; Kelleher A; Grulich AE; Zablotska-Manos I; Cooper D; Triffitt K; Bloch M; McNulty A; Pell C; Emery S, 2019, 'Strategies used by gay male HIV serodiscordant couples to reduce the risk of HIV transmission from anal intercourse in three countries', Journal of the International AIDS Society, 22, pp. e25277, http://dx.doi.org/10.1002/jia2.25277
    Journal articles | 2019
    Vaccher SJ; Marzinke MA; Templeton DJ; Haire BG; Ryder N; McNulty A; Foster R; Grulich AE; Zablotska IB; Bloch M; Carr A; Cheung C; Gianacas C; Guy R; Holt M; Kaldor J; Mackie B; Mayer K; McAllister J; Murphy D; Ooi C; Pell C; Poynten IM; Prestage G; de Wit J; Wright E; Callander D; Cooper D; Crooks L; Duck T; Holden J; Keen P; Kelleher A; Mitchell J; Price K; Selvey C; Schmidt HM; Telfer B; Whittaker B; Wilson D; de Wit J; Cooper D, 2019, 'Predictors of Daily Adherence to HIV Pre-exposure Prophylaxis in Gay/Bisexual Men in the PRELUDE Demonstration Project', AIDS and Behavior, 23, pp. 1287 - 1296, http://dx.doi.org/10.1007/s10461-018-2353-5
    Journal articles | 2019
    Zablotska IB; Vaccher SJ; Bloch M; Carr A; Foster R; Grulich AE; Guy R; McNulty A; Ooi C; Pell C; Poynten IM; Prestage G; Ryder N; Templeton D; Cheung C; Gianacas C; Holt M; Kaldor J; Mackie B; Mayer K; McAllister J; Murphy D; de Wit J; Wright E, 2019, 'High Adherence to HIV Pre-exposure Prophylaxis and No HIV Seroconversions Despite High Levels of Risk Behaviour and STIs: The Australian Demonstration Study PrELUDE', AIDS and Behavior, 23, pp. 1780 - 1789, http://dx.doi.org/10.1007/s10461-018-2290-3
    Journal articles | 2018
    Bavinton BR; Pinto AN; Phanuphak N; Grinsztejn B; Prestage GP; Zablotska-Manos IB; Jin F; Fairley CK; Moore RD; Roth N; Bloch M; Pell C; McNulty AM; Baker D; Hoy J; Tee BK; Templeton DJ; Cooper DA; Emery S; Kelleher A; Grulich AE; Bas A; Cooper DA; Wilson D; Koelsch KK; Triffitt K; Doong N; Baker D; Bloch M; Pell C; Hoy J; Orth D, 2018, 'Viral suppression and HIV transmission in serodiscordant male couples: an international, prospective, observational, cohort study', The Lancet HIV, 5, pp. e438 - e447, http://dx.doi.org/10.1016/S2352-3018(18)30132-2
    Journal articles | 2018
    Callander D; Bourne C; Wand H; Stoové M; Hocking JS; De Wit J; Kaldor JM; Donovan B; Pell C; Finlayson R; Baker D; Forssman B; Tee BK; Kefalas B; Duck T; Guy R, 2018, 'Assessing the impacts of integrated decision support software on sexual orientation recording, comprehensive sexual health testing, and detection of infections among gay and bisexual men attending general practice: Observational study', JMIR Medical Informatics, 20, pp. e10808, http://dx.doi.org/10.2196/10808
    Journal articles | 2018
    Philpot SP; Prestage G; Ellard J; Grulich AE; Bavinton BR; Kelleher A; Bloch M; Pell C; Zablotska-Manos I; Jin J; Cooper D; Wilson D; Triffitt K; Templeton D; McNulty A; Pinto A, 2018, 'How do gay serodiscordant couples in Sydney, Australia negotiate undetectable viral load for HIV prevention?', AIDS and Behavior, 22, pp. 3981 - 3990, http://dx.doi.org/10.1007/s10461-018-2247-6
    Journal articles | 2017
    Vaccher SJ; Gianacas C; Templeton DJ; Poynten IM; Haire BG; Ooi C; Foster R; McNulty A; Grulich AE; Zablotska IB; Pell C; Holt M; Prestage G; Guy R, 2017, 'Baseline preferences for daily, event-driven, or periodic hiv pre-exposure prophylaxis among gay and bisexual men in the prelude demonstration project', Frontiers in Public Health, 5, pp. 341, http://dx.doi.org/10.3389/fpubh.2017.00341
    Journal articles | 2016
    Vaccher S; Grulich A; McAllister J; Templeton DJ; Bloch M; McNulty A; Holden J; Poynten IM; Prestage G; Zablotska I; Carr A; Cheung C; Foster R; Gianacas C; Guy R; Holt M; Kaldor J; Mackie B; Mayer K; Murphy D; Ooi C; Pell C; Ryder N; De Wit J; Wright E, 2016, 'Protocol for an open-label, single-arm trial of HIV pre-exposure prophylaxis (PrEP) among people at high risk of HIV infection: the NSW Demonstration Project PRELUDE', BMJ Open, 6, pp. e012179corr1, http://dx.doi.org/10.1136/bmjopen-2016-012179
    Journal articles | 2015
    Callander D; Bourne C; Pell C; Finlayson R; Forssman B; Baker D; De Wit J; Hocking J; Stoové M; Donovan B; Kaldor J; Guy R, 2015, 'Recording the sexual orientation of male patients attending general practice', Family Practice, 32, pp. 35 - 40, http://dx.doi.org/10.1093/fampra/cmu061
    Journal articles | 2014
    Baker D; Pell C; Donovan B, 2014, 'HIV infection as a chronic disease: Optimising outcomes',
    Journal articles | 2013
    Pell C, 2013, 'Rise in new HIV infections', Australian Family Physician, 42, pp. 8
    Journal articles | 2009
    Guinot D; Ho MT; Poynten IM; McAllister J; Pierce A; Pell CM; Grulich AE, 2009, 'Cost-effectiveness of HIV nonoccupational post-exposure prophylaxis in Australia', HIV Medicine, 10, pp. 199 - 208, http://dx.doi.org/10.1111/j.1468-1293.2008.00670.x
    Journal articles | 2008
    Bodsworth N; Bloch M; McNulty A; Denham I; Doong N; Trottier S; Adena M; Bonney MA; Agnew J; Abdurahman I; Ajam A; Alexander R; Aung A; Barry S; Becker B; Belbin M; Bishop C; Bisshop F; Bourne C; Brett T; Brown K; Butler A; Carmody C; Chan D; Chuah J; Conway D; Daly C; Davies S; Davis C; Davis B; Dever N; Donovan B; Eisen D; Eliades C; Elisha B; Fairley C; Feiglin A; Freeman A; Furner V; Garland S; Genn W; Giannakopoulos J; Glass F; Gold J; Goswami J; Gowers A; Grech J; Hackney P; Hanson B; Hartnell K; Harvey C; Hasan M; Hawkins S; Heley S; Herbst D; Hespe C; Irlicht M; Isaacs A; Katahanas L; Kelly M; Komarowski P; Kostic G; Kozminsky M; Lagios K; Lee D; Lewis P; Liang T; Lyttle H; Mackellar-Michelmore H; Macleod H; Marsh L; Marshall L; McCloskey J; McCurdy D; McEvoy P; McFarlane R; McKeegan P; McMurchie M; McNamee K; Medland N; Menon A; Meyerowitz C; Michaels W; Mobbs M; Montague A; Nicola N; Nurcombe C; O'Connor C; Ooi C; Ostrowskyl O; O'Sullivan M; Owen L; Papp K; Patten J; Panopoulous D; Pell C; Philpot R; Quan D; Quin J; Rhodes D, 2008, '2-Day versus 5-day famciclovir as treatment of recurrences of genital herpes: Results of the FaST study (Sexual Health (2008) 5, 3, (219-225))', Sexual Health, 5, pp. 379, http://dx.doi.org/10.1071/SH08013_CO
    Journal articles | 2008
    Bodsworth NJ; Bloch MT; Mcnulty A; Denham I; Doong N; Trottier S; Adena MA; Bonney M; Agnew J; Australo-Canadian Fast A, 2008, '2-day versus 5-day famciclovir as treatment of recurrences of genital herpes: Results of the FaST study', Sexual Health, 5, pp. 219 - 225
    Journal articles | 2007
    Calmy A; Petoumenos K; Lewden C; Law MG; Bocquentin F; Hesse K; Cooper DA; Carr AD; Bonnet F, 2007, 'Combination antiretroviral therapy without a nucleoside reverse transcriptase inhibitor: experience from 334 patients in three cohorts', HIV Medicine, 8, pp. 171 - 180
    Journal articles | 2007
    Jin F; Prestage G; Kippax SC; Pell CM; Donovan BJ; Templeton DJ; Kaldor JM; Grulich AE, 2007, 'Risk factors for genital and anal warts in a prospective cohort of HIV-negative homosexual men: The HIM study', Sexually Transmitted Diseases, 34, pp. 488 - 493, http://dx.doi.org/10.1097/01.olq.0000245960.52668.e5
    Journal articles | 2007
    Jin F; Prestage GP; Imrie JCG; Kippax SC; Pell CM; Donovan B; Templeton DJ; Cunningham PH; Cunningham AL; Mindel A; Kaldor JM; Grulich AE, 2007, 'Anal sexually transmissible infections as risk factors for HIV seroconversion', SEXUAL HEALTH, 4, pp. 294 - 294, http://dx.doi.org/10.1071/SHv4n4Ab25
    Journal articles | 2007
    Savage J; Pell C; Pierce A; Aitken S; Anderson G; Daye J; Grulich A; Haire B; Kambourakis T; Latif A; Macaulay C; Marshall L; McAllister J; Wright E, 2007, 'National guidelines for post-exposure prophylaxis after non-occupational exposure to HIV', Sexual Health, 4, pp. 277 - 283, http://dx.doi.org/10.1071/SH07067
    Journal articles | 2006
    Jin F; Prestage G; Mao L; Kippax SC; Pell CM; Donovan BJ; Templeton DJ; Taylor J; Mindel A; Kaldor JM; Grulich AE, 2006, 'Transmission of herpes simplex virus types 1 and 2 in a prospective cohort of HIV negative gay men: The Health in Men Study', Journal of Infectious Diseases, 194, pp. 561 - 570, http://dx.doi.org/10.1086/506455
    Journal articles | 2006
    Pell C; Dabbhadatta J; Harcourt C; Tribe K; O'Connor C, 2006, 'Demographic, migration status, and work-related changes in Asian female sex workers surveyed in Sydney, 1993 and 2003', Australian and New Zealand Journal of Public Health, 30, pp. 157 - 162, http://dx.doi.org/10.1111/j.1467-842X.2006.tb00110.x
    Journal articles | 2005
    Jin F; Prestage G; Pell CM; Donovan BJ; Kippax SC; Kaldor JM; Grulich AE, 2005, 'Hepatitis A and B infection and vaccination in the Health in Men (HIM) cohort', Australian HIV Surveillance Report, 21, pp. 1 - 4
    Journal articles | 2005
    Petoumenos K; Ringland C, 2005, 'Antiretroviral treatment change among HIV, hepatitis B virus and hepatitis C virus co-infected patients in the Australian HIV Observational Database', HIV Medicine, 6, pp. 155 - 163
    Journal articles | 2004
    Fin F; Prestage G; Pell CM; Donovan BJ; Van der ven P; Kippax SC; Kaldor JM; Grulich AE, 2004, 'Hepatitis A and B infection and vaccination in a cohort of homosexual men in Sydney, Australia', Sexual Health, 1, pp. 227 - 237
    Journal articles | 2004
    Jin F; Prestage G; Pell CM; Donovan BJ; Van De Ven PG; Kippax SC; Kaldor JM; Grulich AE, 2004, 'Hepatitis A and hepatitis B infection and vaccination in a cohort of homosexual men in Sydney', Sexual Health, 1, pp. 227 - 237
    Journal articles | 2004
    Ledergerber B; Lundgren JD; Sarah Walker A; Sabin C; Justice A; Reiss P; Mussini C; Wit F; d'Arminio Monforte A; Weber R; Fusco G; Staszewski S; Law M; Hogg R; Lampe F; John Gill M; Castelli F; Phillips AN; Rooney P; Taylor S; Couldwell D; Austin D; Block M; Clemons J; Finlayson R; Petoumenos K; Quan D; Smith D; O'Connor C; Gorton C; Allen D; Mulhall B; Mutimer K; Keeffe N; Cooper D; Carr A; Miller J; Pell C; Ellis D; Baker D; Kidd J; McFarlane R; Liang MT; Brown K; Huffam S; Savage J; Morgan S; Knibbs P; Sowden D; Walker A; Orth D; Lister G; Chuah J; Fankhauser W; Dickson B; Bradford D; Wilson C; Ree H; Magon H; Anderson J; Moore R; Russell D; McGovern G; McNair R; Bal J; Fairley K; Roth N; Eu B; Strecker S; Wood H; Mijch A; Hoy J; Pierce A; McCormack C; Watson K; Medland N; Daye J; Mallal S; French M; Skett J; Maxwel D; Cain A; Montroni M; Scalise G; Costantini A; Giacometti A; Tirelli U; Nasti G; Pastore G; Ladisa N; Perulli ML; Suter F; Arici C; Maggiolo F; Chiodo F; Gritti FM; Colangeli V; Fiorini C; Guerra L; Carosi G, 2004, 'Predictors of trend in CD4-positive T-cell count and mortality among HIV-1-infected individuals with virological failure to all three antiretroviral-drug classes', Lancet, 364, pp. 51 - 62, http://dx.doi.org/10.1016/S0140-6736(04)16589-6
    Journal articles | 2003
    Lincoln DW; Petoumenos K; Dore GJ, 2003, 'HIV/HBV and HIV/HCV coinfection, and outcomes following highly active antiretroviral therapy', HIV Medicine, 4, pp. 241 - 249
    Journal articles | 1999
    Pell CM; Donovan B; Bodsworth NJ, 1999, 'Efficacy and tolerability of the combination stavudine, didanosine and nevirapine following treatment with HIV-1 protease inhibitors', Venereology, 12, pp. 145 - 146
  • Preprints | 2020
    Dawson M; Dharan N; Yeh P; Bloch M; Yeung M; Baker D; Guinto J; Roth N; Ftouni S; Ognenovska K; Smith D; Hoy J; Woolley I; Pell C; Templeton D; Fraser N; Rose N; Hutchinson J; Petoumenos K; Dawson S-J; Polizzotto M, 2020, Age-related clonal haematopoiesis is more prevalent in older adults with HIV: the ARCHIVE study, , http://dx.doi.org/10.21203/rs.3.rs-106576/v1
    Preprints | 2020
    Dharan N; Yeh P; Bloch M; Yeung M; Baker D; Guinto J; Roth N; Ftouni S; Ognenovska K; Smith D; Hoy J; Woolley I; Pell C; Templeton D; Fraser N; Rose N; Hutchinson J; Petoumenos K; Dawson S-J; Polizzotto M; Dawson M; for the ARCHIVE Study Group , 2020, Age-related clonal haematopoiesis is more prevalent in older adults with HIV: the ARCHIVE study, , http://dx.doi.org/10.1101/2020.11.19.20235069
    Reports | 2015
    Callander DJ; Bourne C; Pell C; Baker D; Forssman B; Gowers A; Tee B; Kefalas B; Duck T; Roberts A; Stoove M; Hocking J; de Wit J; Kaldor J; Donovan B; Guy R, 2015, An initiative to enhance STI testing in gay men: The eTEST Project Final report, Kirby Institute, UNSW Australia, Sydney, NSW, http://dx.doi.org/10.26190/unsworks/25936, http://kirby.unsw.edu.au/sites/default/files/hiv/attachment/The%20eTEST%20Project%20-%20Final%20Report.pdf
    Conference Papers | 2008
    Jin F; Prestage G; Imrie JC; Kippax SC; Pell CM; Donovan BJ; Templeton DJ; Cunningham PH; Cunningham AL; Mindel A; Kaldor JM; Grulich AE, 2008, 'Anal sexually transmissible infections as risk factors for HIV seroconversion', in Sexual Health, CSIRO Publishing, Australia, pp. 25 - 25, presented at Sexual Health, Perth, 17 September 2008 - 20 September 2008
    Conference Papers | 2004
    Corey L; Ashley R; McCloskey J; Denham I; Patten J; Pell C; Waddell R; Sodre CT; Bouchard C; Diaz-Mitoma FJ; Lassonde MG; Romanowski B; Sacks SL; Trottler S; Gubelin W; Guglielmetti A; Diaz J; Rubiano N; Roed-Petersen J; Thestrup-Pedersen K; Wulff HC; Kivimagi K; Poder A; Paavonen J; Saari S; Simpanen AL; Morel P; Ortonne JP; Cardamakis E; Mourelou O; Bornstein J; Dolitzky M; Dainys B; Laiskonis A; Soto RG; Pulido Olivares VH; Cairo I; Arama V; Balasoiu V; Capalna M; Giurcaneanu C; Popescu S; Tarlea V; Koubanova A; Martchenko L; Semenova T; Stratchounsky L; Ballesteros J; Varela JA; Strand A; Atakan N; Ozarmagan G; Adkins GM; Baker DA; Beutner KR; Beyerlein RA; Brady R; Cabezas-Mijuste M; Clark S; Conant M; Drehobl MA; Douglas J; Faro S; Fife KH; Funk S; Gartman D; Garza G; Hart DC; Holmes JA; Koltun WD; Kraus SJ; Kurtz T; Landwermeyer MA; Leone PA; Levin MJ; Marbury TC; Marlowe SI; Marques A; Mertz G; Nett R; Pogue B; Poretz DM; Rosen J; Rowe DH; Salazar G; Schacker TW; Seraly M; Spencer RP; Stern J; Stone S; Thomas E; Tyring SK; Wald A; Warren T; Whiting DA; Wiener ML; Wiesenfeld H; Bowman C, 2004, 'Prevention of herpes simplex virus type 2 transmission with antiviral therapy', in Herpes